Literature DB >> 26559248

Red and Processed Meat Consumption Increases Risk for Non-Hodgkin Lymphoma: A PRISMA-Compliant Meta-Analysis of Observational Studies.

Li Yang1, Jianming Dong, Shenghua Jiang, Wenyu Shi, Xiaohong Xu, Hongming Huang, Xuefen You, Hong Liu.   

Abstract

The association between consumption of red and processed meat and non-Hodgkin lymphoma (NHL) remains unclear. We performed a meta-analysis of the published observational studies to explore this relationship.We searched databases in MEDLINE and EMBASE to identify observational studies which evaluated the association between consumption of red and processed meat and risk of NHL. Quality of included studies was evaluated using Newcastle-Ottawa Quality Assessment Scale (NOS). Random-effects models were used to calculate summary relative risk (SRR) and the corresponding 95% confidence interval (CI).We identified a total of 16 case-control and 4 prospective cohort studies, including 15,189 subjects with NHL. The SRR of NHL comparing the highest and lowest categories were 1.32 (95% CI: 1.12-1.55) for red meat and 1.17 (95% CI: 1.07-1.29) for processed meat intake. Stratified analysis indicated that a statistically significant risk association between consumption of red and processed meat and NHL risk was observed in case-control studies, but not in cohort studies. The SRR was 1.11 (95% CI: 1.04-1.18) for per 100 g/day increment in red meat intake and 1.28 (95% CI: 1.08-1.53) for per 50 g/day increment in processed meat intake. There was evidence of a nonlinear association for intake of processed meat, but not for intake of red meat.Findings from our meta-analysis indicate that consumption of red and processed meat may be related to NHL risk. More prospective epidemiological studies that control for important confounders and focus on the NHL risk related with different levels of meat consumption are required to clarify this association.

Entities:  

Mesh:

Year:  2015        PMID: 26559248      PMCID: PMC4912242          DOI: 10.1097/MD.0000000000001729

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


INTRODUCTION

Non-Hodgkin lymphoma (NHL) is a heterogeneous group of malignancies arising from lymphoid tissue. Established risk factors, such as immunodeficiency and viral infection, are only responsible for a small proportion of cases.[1] In addition to these, it is thought that certain medical conditions[2] and lifestyle factors, including obesity[3] and tobacco smoking,[4] may be implicated. Although the evidence is both inconsistent and limited, it has been suggested that dietary factors may also play a role in the development of NHL.[5,6] Consumption of red and processed meat has long been known to be associated with an increased risk of various cancers, such as of the colorectum, esophagus (squamous cell carcinoma), liver, lung, and prostate.[7] Heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs), formed during cooking of meat at high temperatures, are well-established carcinogens.[8-10] In addition, N-nitroso compounds (NOCs), which are formed in processed meat containing high levels of nitrates and nitrites, are also implicated in the development of various human tumors. Many epidemiological studies have investigated the association between the consumption of red and processed meat and the risk of NHL, with mixed results.[11-30] Based on a meta-analysis of the data from 3 cohort and 8 case–control studies, Fallahzadeh and colleagues concluded that high consumption levels of red and processed meat may increase the risk of NHL. However, there was significant heterogeneity between studies (P < 0.01).[6] Unfortunately, they failed to include several relevant studies,[11,12,14,15,21-23,27,28] and did not explore the source of the heterogeneity. In addition, the dose–response relationship between the consumption of red and processed meat and the risk of NHL has not been clearly defined. In order to better understand this, we carried out a comprehensive meta-analysis of observational studies, using our own methods and criteria for the selection of studies, in the presentation of the data, in the interpretation of the evidence, and in the conclusions drawn.

METHODS

We performed a meta-analysis of the association between the consumption of red and processed meat and the risk of NHL, following the PRISMA criteria.[31] Given that the data used had all been published previously, ethics committee approval was not required. The searches, selection of studies for inclusion, data extraction, and the quality assessments were performed independently by 2 of the authors (YL and DJM); disagreements were resolved by discussion.

Data Sources and Searches

Studies published in English up to the end of January 2015 were eligible for inclusion. We performed MEDLINE and EMBASE searches using the following key words and strategies: cancer or lymphoma; and red meat or processed meat or preserved meat or beef or pork or veal or mutton or lamb or ham or sausage or bacon; and risk or incidence or prevalence. Potentially relevant papers were retrieved and assessed. The references in the articles were checked to identify additional publications of interest.

Study Selection

The definitions of red and processed meat varied across studies. For the purposes of the study we defined red meat as beef, veal, pork and lamb, or any combination thereof. We defined processed meat as products made from pork, beef, or lamb that had been preserved by curing, smoking, frying, or drying.[13] Studies of the association between red and processed meat consumption and the risk of NHL were eligible for inclusion if they were observational (cohort or case–control), undertaken in humans, and reported relative risk (RR) estimates (hazard ratios, risk ratios, or odds ratios) with corresponding 95% confidence intervals (CIs). We excluded experimental and mechanistic studies, nonpeer reviewed articles, ecologic assessments, and correlation studies. We also excluded studies published only as abstracts or commentaries. When multiple reports were available on the same study, only the most informative one was considered.

Data Extraction

Information on study design, location, publication year, number of subjects (cases, controls, or cohort size), type of controls, duration of follow-up for cohort studies, dietary assessments, comparison groups, methods of outcome assessment, RR estimates and the corresponding CIs for the highest versus lowest intake level, and adjustment variables was extracted. The RRs were determined using the most adjusted multivariate model. For the purposes of the analysis, one study, which reported results according to t(14;18) status,[21] was considered by us as being 2 separate ones. Another study analyzed their data according to the method used for meat processing.[18] We extracted from it the findings pertaining to fried red meant, as this accounted for most of the processed meat consumed.

Quality Assessment of Individual Studies

A quality assessment of included studies was undertaken using the Newcastle-Ottawa Scale (NOS).[32] This instrument assesses the quality of case–control and cohort studies against three parameter: selection (4 items, with each being awarded 1 star), comparability (1 item, which can be awarded up to 2 stars), and exposure/outcome (3 items, with each being awarded 1 star). A score of ≥7 stars is indicative of a high quality study. Studies for which there was insufficient information available for NOS scoring were considered to be of low quality.

Statistical Methods

We calculated summary relative risk (SRR) and 95% CI to measure the impact of the highest versus the lowest level of red and processed meat consumption on the risk of NHL using a random effect model, according to the method described by DerSimonian and Laird,[33] which takes into account both within and between study heterogeneity. When sex-specific estimates were available, we analyzed for this separately. To evaluate the between-study heterogeneity of included studies, we used the χ2 test, defining significant heterogeneity as a P-value < 0.10, and assessed inconsistency using the I2 statistic. An I2 value of over 50% indicates that high between-study heterogeneity may be present. An I2 value of under 25% indicates no significant heterogeneity.[34] We carried out strata and linear meta-regression analysis based on geographic locations, study design (case–control vs. cohort study), type of food frequency questionnaires (FFQs, validated vs. not validated), study quality score, number of cases, and confounders (smoking status, body mass index [BMI], alcohol use, dietary energy intake, and vegetable and fruit intake). We also examined the associations for subtypes of NHL (diffuse large B-cell lymphoma [DLBCL], follicular lymphoma [FL], small lymphocytic lymphoma/chronic lymphocytic leukemia [SLL/CLL], and T-cell lymphoma). Sensitivity analyses were conducted by omitting one study at a time and examining the influence of each individual study on the overall RR. When possible, linear dose–response analysis was carried out per increment in consumption of 100 g of red meat and 50 g of processed meat daily using generalized least-squares trend estimation (GLST) analysis, as developed by Greenland and Orsini.[35,36] This method requires medians for ≥3 category levels of consumption. When medians were not available, we calculated the midpoint of the upper and lower boundaries in each category as the average intake level. When the lowest category was open ended, the lowest boundary was considered as zero. When the highest category was open ended, the open-ended boundary was calculated using an interval length of the width of the closest interval. When exposure was reported as frequency of consumption, as in the World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) report,[37] we transformed the quantitative exposure units into grams per day by assuming that a standard “serving” or “portion” corresponded to 120 g for red meat and 50 g for processed meat. For studies reporting intakes in grams/1000 kcal/day,[25,26,30] the intake in grams/day was estimated using the average energy intake reported in the relevant article. We carried out a potential nonlinear dose–response analysis using the best-fitting 2-term fractional polynomial regression model.[38] A likelihood ratio test was used to assess the difference between the nonlinear and linear models to test for nonlinearity.[38] To evaluate publication bias, we used the contour enhanced funnel plot and the Egger regression test.[39] All statistical analyses were performed using STATA, version 11.0 (STATA, College Station, TX) and R-package (Version 2.11.0 beta, R Development Core Team, Auckland, NJ) statistical software. A 2-tailed P-value of <0.05 represented significance.

RESULTS

Search Results and Study Characteristics

The search strategy generated 7015 citations (Fig. 1). From the reference review, we included an additional 156 articles. On the basis of the titles and abstracts, we identified 72 potentially relevant articles. Of these, 39 were subsequently assessed as being nonrelevant, 6 were excluded because they did not report the odds ratio (OR) or RR and the corresponding 95% CI, or sufficient information to calculate them. One was excluded because it reported for the association between dietary pattern and NHL risk. Seven articles were excluded on the basis that they represented multiple reports of the same study. This left 20 eligible studies, published between 1996 and 2013. They comprised 4 prospective cohort studies,[11,13,24,26] and 9 population-based[16-18,21-23,25,30,40] and 7 hospital-based case–control studies[12,14,15,20,27-29] (Table 1  ). A total of 15,189 subjects with NHL were included. Eleven studies were from the North America, 5 from Europe, 2 from Asia, and 2 from Uruguay. All used FFQs for the assessment of meat consumption. Most considered or adjusted for the effects of smoking, alcohol consumption, BMI, and total energy intake. The NOS scores ranged from 6 to 9; seventeen studies were deemed to be of a high quality (≥7 stars) (Suppl. Table 1, http://links.lww.com/MD/A508).
FIGURE 1

Flow diagram of the systematic literature search on red and processed meat intake and the risk of non-Hodgkin lymphoma.

TABLE 1

Characteristics of Studies of Red and Processed Meat Consumption and Non-Hodgkin Lymphoma Risk

Flow diagram of the systematic literature search on red and processed meat intake and the risk of non-Hodgkin lymphoma. Characteristics of Studies of Red and Processed Meat Consumption and Non-Hodgkin Lymphoma Risk Characteristics of Studies of Red and Processed Meat Consumption and Non-Hodgkin Lymphoma Risk Characteristics of Studies of Red and Processed Meat Consumption and Non-Hodgkin Lymphoma Risk

Red Meat

High Versus Low intake analysis

The summary RR of NHL for the highest group compared with the lowest group of red meat intake was 1.32 (95% CI, 1.12–1.55). There was evidence of strong between study heterogeneity across these studies (Pheterogeneity < 0.001, I2 = 79.0%, Fig. 2A).
FIGURE 2

The summary risk association between red meat intake and risk of non-Hodgkin lymphoma according to (A) the highest versus lowest intake analysis; (B) linear dose–response analysis (per 100 g/day increment); (C) nonlinear dose–response analysis based on the best-fitting 2-term fractional polynomial regression model.

The summary risk association between red meat intake and risk of non-Hodgkin lymphoma according to (A) the highest versus lowest intake analysis; (B) linear dose–response analysis (per 100 g/day increment); (C) nonlinear dose–response analysis based on the best-fitting 2-term fractional polynomial regression model.

Dose–Response Analysis

Thirteen studies could be used in the dose–response meta-analysis. The SRR of NHL was 1.11 (95% CI, 1.04–1.18) per 100 g/day of red meat, with evidence of moderate between study heterogeneity (Pheterogeneity = 0.067, I2 = 39.0%, Fig. 2B). There was no evidence of a nonlinear association of red meat intake and NHL risk (P = 0.351, Fig. 2C).

Processed Meat

High Versus Low Intake Analysis

The SRR of NHL for the highest group compared to the lowest group of processed meat intake was 1.17 (95% CI, 1.07–1.29). There was evidence of moderate between study heterogeneity (Pheterogeneity = 0.057, I2 = 37.1%, Fig. 3A).
FIGURE 3

The summary risk association between processed meat intake and risk of non-Hodgkin lymphoma according to (A) the highest versus lowest intake analysis; (B) linear dose–response analysis (per 50 g/day increment); (C) nonlinear dose–response analysis based on the best-fitting 2-term fractional polynomial regression model.

The summary risk association between processed meat intake and risk of non-Hodgkin lymphoma according to (A) the highest versus lowest intake analysis; (B) linear dose–response analysis (per 50 g/day increment); (C) nonlinear dose–response analysis based on the best-fitting 2-term fractional polynomial regression model.

Dose–Response Analysis

Fourteen studies could be used in the dose–response meta-analysis. The SRR of NHL was 1.28 (95% CI, 1.08–1.53; Pheterogeneity < 0.001; I2 = 72.4%; Fig. 3B) per 50 g/day of processed meat. There was evidence of a nonlinear association of processed meat intake and NHL risk (P = 0.031, Fig. 3C).

Publication Bias

Egger test did not reveal evidence of publication bias for either red meat (P = 0.567, Suppl. Figure 1A, http://links.lww.com/MD/A508) and processed meat consumption (P = 0.181, Suppl. Figure 1B, http://links.lww.com/MD/A508).

Subgroup, Meta-Regression and Sensitivity Analyses

The results of stratified and meta-regression analyses are shown in Table 2. For red meat consumption, we observed an increased risk of NHL in case–control studies (SRR = 1.34; 95% CI, 1.09–1.65), but not in cohort studies (SRR = 1.17; 95% CI, 0.92–1.49). The pooled RR was 2.12 (95% CI, 0.80–5.59; n = 3 studies) for men and 1.61 (95% CI, 1.06–2.45; n = 4 studies) for women. There was significant between-subgroup heterogeneity between studies which used different FFQs (validated vs. not validated, P for difference = 0.09), were of different quality (high vs. low, P for difference = 0.087), and followed adjustments for vegetable and fruits intake (P for difference = 0.051). This partly explained the overall high heterogeneity.
TABLE 1 (Continued)

Characteristics of Studies of Red and Processed Meat Consumption and Non-Hodgkin Lymphoma Risk

Stratified Meta-Analyses of Intake of Red and Processed Meat and Non-Hodgkin Lymphoma Risk For processed meat consumption, we found an increased risk of NHL in case–control studies (SRR = 1.21; 95% CI, 1.07–1.36), but not in cohort studies (SRR = 1.07; 95% CI, 0.97–1.19). There was significant between-subgroup heterogeneity between studies when adjusted for BMI (P for difference = 0.018). This partly explained the overall high heterogeneity. The estimation of overall homogeneity and the effect of removing one study at a time from the analysis confirmed the stability of the relationship between red and processed meat intake and NHL risk (data not shown). In addition, repeat analysis of high versus low intake using the studies included in the linear dose–response analysis yielded results similar to those of the original analysis (red meat: SRR = 1.20; 95% CI, 1.07–1.35; Pheterogeneity = 0.045; I2 = 42.8% and processed meat: SRR = 1.17; 95% CI, 1.05–1.30; Pheterogeneity = 0.029; I2 = 44.3%).

NHL Subtypes

Six studies[18,24-26,28,30] gave risk estimates for the association between red and processed meat consumption and NHL subtypes. We found a significant association between processed meat consumption and DLBCL risk (SRR = 1.23; 95% CI, 1.03–1.48), but no other significant associations (Fig. 4A and B).
FIGURE 4

Intake of red (A) and processed meat (B) and risk of the subtypes of Non-Hodgkin lymphoma. FL, follicular lymphoma, DLBCL, diffuse large B-cell lymphoma, SLL/CLL, small lymphocytic lymphoma/chronic lymphocytic leukemia.

Intake of red (A) and processed meat (B) and risk of the subtypes of Non-Hodgkin lymphoma. FL, follicular lymphoma, DLBCL, diffuse large B-cell lymphoma, SLL/CLL, small lymphocytic lymphoma/chronic lymphocytic leukemia.

Individual Meat Items

Intake of salted meat and fried meat were positively associated with NHL risk (salted meat: SRR = 2.34; 95% CI, 1.68–3.26 and fried meat: SRR = 1.27; 95% CI, 1.01–1.63), but this was based on only two[12,29] and three studies,[13,18,19] respectively (Suppl. Table 2, http://links.lww.com/MD/A508). The risk of NHL was not positively associated with the intake of any other meat items, such as bacon, barbecued/grilled/broiled meat, or hamburgers. As an example, 4 individual studies[11,12,15,30] reported an association between beef intake and NHL risk. They yielded an SRR of 1.30 (95% CI, 0.97–1.74; Pheterogeneity = 0.186; I2 = 35.2%).

DISCUSSION

This detailed meta-analysis found that red and processed meat intake is associated with an increased risk of NHL. The estimated increase in risk found for high versus low consumption was 32% for red meat and 17% for processed meat. There was significant heterogeneity between studies for both red and processed meat intake. The findings were consistent with those obtained from linear dose–response meta-analysis. In nonlinear models, NHL risk appeared to increase approximately linearly with increasing intake of red meat, whereas there was evidence of nonlinearly of risk with increasing intake of processed meat. Our findings are consistent with those of a previous much smaller meta-analysis of 3 cohort and 8 case–control studies which found a positive association between red and processed meat intake and the risk of NHL.[6] Our results, based on 16 case–control and 4 prospective cohort studies, are as striking. We examined the nature of the dose response relationship between consumption of red and processed meat and NHL risk in greater detail than did the previous meta-analysis, and found a positive dose–response relationship with increasing dietary red and processed meat intake. The Iowa Women's Health Study (IWHS) found that greater consumption of red meat (RR = 1.98; 95% CI, 1.13–3.47; P for trend = 0.02), and hamburgers in particular (RR = 2.35; 95% CI, 1.23–4.48; P for trend = 0.02) was associated with an increased risk of NHL.[11] Similarly, the Nurse's Health Study reported an increased risk of NHL with greater red meat intake (P for trend = 0.002).[13] In contrast, the European Prospective Investigation into Cancer and Nutrition (EPIC)[24] and the NIH-AARP Diet and Health Study[26] found no consistent associations between red and processed meat consumption and NHL risk. Our meta-analysis found that red and processed meat consumption was significantly associated with an increased risk of NHL in case–control, but not in cohort, studies. Case–control studies are more susceptible to recall, particularly dietary recall, and selection biases, than are cohort studies. Information on dietary exposure was obtained after NHL had been diagnosed in the case–control studies included in our meta-analysis. These data may have been confounded by recall bias and inaccurate estimation of meat intake. Therefore, the finding that red and processed meat consumption is associated with an increased NHL risk should be treated with caution. We undertook separate analyses of the risks for subtypes of NHL. We found no statistically significant associations between red and processed meat consumption and subtypes of NHL, except for that between processed meat consumption and DLBCL. However, these analyses were based on a maximum of 5 studies and may have lacked the power necessary to detect some associations. Clearly, further larger studies addressing this topic are required. Similar caution is appropriate when considering our findings on the relationship between red and processed meat consumption and the risk of NHL according to sex. A maximum of 4 studies were used for this analysis. For processed meat consumption, we found an association in both men and women, but for red meat, we found an association only in women. A number of mechanisms to explain how red and processed meat intake might increase the risk of malignancies, including NHL, have been proposed. Known mutagens, such as HCAs and PAHs, are found in high concentrations in well-done grilled and pan fried meat. HCAs may be immunotoxic.[41] They have been found to increase the NHL risk in rodent models[28,42] and in a human study.[43] High saturated fat and animal protein content, as found in red and processed meat, has been positively associated with NHL risk in some studies;[11,17] although others have found the converse[19] or a lack of any association.[13,16] Other potential mechanisms which might underlie an increased risk of NHL risk with red and processed meat consumption, involve NOCs, which have been linked to the risk of lymphoma in humans.[44,45] In comparison of the previous meta-analysis,[6] ours has the advantage that it included more observational studies, allowing us to undertake both high versus low exposure and linear and nonlinear dose–response meta-analyses. In addition, we conducted a rigorous quality assessment. Finally, by undertaking a sensitivity analysis, we were able to explore the source of heterogeneity between studies. However, our meta-analysis has several limitations. We found there was considerable heterogeneity between studies, especially concerning red meat consumption. Based on the subgroup meta-regression analysis, we found that the type of FFQ, study quality score and the adjustments made for vegetable and fruits intake might partially account for this. With regards to the association between processed meat consumption and NHL risk, we found evidence that this might be partially a consequence of adjustments made for BMI. We also found there to be considerable heterogeneity between studies in the dose–response analyses of processed meat consumption; this might have partially been a consequence of the conversions made to the intake units. These were variously reported as g/day, servings/week, g/1000 kcal/day, and servings per month. We converted all of these to g/day by assuming that a serving corresponds to 50 g of processed meat. A further consideration is that inaccurate assessments of red and processed meat intake could have led to overestimations of the range of intakes, and thus underestimation of the magnitude of the relationship between dietary intake and the risk of NHL.[46,47] Semiquantitative FFQs were used for dietary assessment in all studies. However, these had not all been validated. Subgroup analyses showed that use of validated versus nonvalidated FFQs significantly affected the association between red meat intake and NHL risk. Another challenge we had to deal with was the variation in the definitions and categorization of red and processed meat between studies and in the analytical methods used in different studies. One example of this is the various ways that consumption was quantified: portions per week, times per month, grams per day, or servings per day. Residual confounders are always a concern in observational studies. For example, individuals who eat more red and processed meat may also have higher rates of smoking, alcohol use and obesity, and eat less vegetable and fruit. Subgroup analysis according to studies controlled for these factors, we found that vegetable and fruit intake was a significant factor for red meat intake and NHL risk and that BMI was a significant factor for processed meat consumption and NHL risk, suggesting that vegetable and fruit intake and BMI are potential confounding factors. Only 1 study considered the possible confounding effect of infection with the hepatitis B and C viruses,[14] both of which are known to associated with an increased risk of NHL.[20,48] Other confounding factors cannot be excluded. Finally, as is the case for all meta-analysis, there is the possibility of publication bias, since small studies with negative results tend not to be published. However, the funnel plot analysis and formal statistical tests did not provide evidence for this. In conclusion, our data suggest that heavy consumption of red and processed meat may increase the risk of NHL. However, because the effect was only found in case–control studies and might be a consequence of biases and confounding factors, large scale, prospective epidemiological studies that control for possible confounders and examine the incidence of NHL in relation to the level of meat consumption are required.
TABLE 1 (Continued)

Characteristics of Studies of Red and Processed Meat Consumption and Non-Hodgkin Lymphoma Risk

TABLE 2

Stratified Meta-Analyses of Intake of Red and Processed Meat and Non-Hodgkin Lymphoma Risk

  45 in total

1.  A strategy for modelling the effect of a continuous covariate in medicine and epidemiology.

Authors:  P Royston
Journal:  Stat Med       Date:  2000-07-30       Impact factor: 2.373

2.  Food groups and risk of non-Hodgkin lymphoma: a multicenter, case-control study in Italy.

Authors:  Renato Talamini; Jerry Polesel; Maurizio Montella; Luigino Dal Maso; Marina Crovatto; Anna Crispo; Michele Spina; Vincenzo Canzonieri; Carlo La Vecchia; Silvia Franceschi
Journal:  Int J Cancer       Date:  2006-06-01       Impact factor: 7.396

3.  Meat intake is not associated with risk of non-Hodgkin lymphoma in a large prospective cohort of U.S. men and women.

Authors:  Carrie R Daniel; Rashmi Sinha; Yikyung Park; Barry I Graubard; Albert R Hollenbeck; Lindsay M Morton; Amanda J Cross
Journal:  J Nutr       Date:  2012-04-25       Impact factor: 4.798

4.  Consumption of meat and dairy and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Sabine Rohrmann; Jakob Linseisen; Marianne Uhre Jakobsen; Kim Overvad; Ole Raaschou-Nielsen; Anne Tjonneland; Marie Christine Boutron-Ruault; Rudolf Kaaks; Nikolaus Becker; Manuela Bergmann; Heiner Boeing; Kay-Tee Khaw; Nicholas J Wareham; Timothy J Key; Ruth Travis; Vassiliki Benetou; Androniki Naska; Antonia Trichopoulou; Valeria Pala; Rosario Tumino; Giovanna Masala; Amalia Mattiello; Magritt Brustad; Eiliv Lund; Guri Skeie; H Bas Bueno-de-Mesquita; Petra H M Peeters; Roel C H Vermeulen; Paula Jakszyn; Miren Dorronsoro; Aurelio Barricarte; Maria-Jose Tormo; Esther Molina; Marcial Argüelles; Beatrice Melin; Ulrika Ericson; Jonas Manjer; Sabina Rinaldi; Nadia Slimani; Paolo Boffetta; Anne-Claire Vergnaud; Aneire Khan; Teresa Norat; Paolo Vineis
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

5.  Risk of non-Hodgkin lymphoma and nitrate and nitrite from the diet in Connecticut women.

Authors:  Briseis A Kilfoy; Mary H Ward; Tongzhang Zheng; Theodore R Holford; Peter Boyle; Ping Zhao; Min Dai; Brian Leaderer; Yawei Zhang
Journal:  Cancer Causes Control       Date:  2010-03-05       Impact factor: 2.506

6.  The epidemiological evidence concerning intake of mutagenic activity from the fried surface and the risk of cancer cannot justify preventive measures.

Authors:  G Steineck; M Gerhardsson de Verdier; E Overvik
Journal:  Eur J Cancer Prev       Date:  1993-07       Impact factor: 2.497

7.  Red meat intake and cancer risk: a study in Italy.

Authors:  A Tavani; C La Vecchia; S Gallus; P Lagiou; D Trichopoulos; F Levi; E Negri
Journal:  Int J Cancer       Date:  2000-05-01       Impact factor: 7.396

8.  Meat, milk and risk of lymphoid malignancies: a case-control study in Uruguay.

Authors:  Eduardo De Stefani; Alvaro L Ronco; Hugo Deneo-Pellegrini; Paolo Boffetta; Pelayo Correa; Enrique Barrios; Gisele Acosta; María Mendilaharsu
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

9.  Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: a case-control analysis.

Authors:  Mark P Purdue; Diego G Bassani; Neil S Klar; Margaret Sloan; Nancy Kreiger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-10       Impact factor: 4.254

10.  Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and effect of dietary fat.

Authors:  A Ghoshal; K H Preisegger; S Takayama; S S Thorgeirsson; E G Snyderwine
Journal:  Carcinogenesis       Date:  1994-11       Impact factor: 4.944

View more
  6 in total

Review 1.  Processed meat intake and incidence of colorectal cancer: a systematic review and meta-analysis of prospective observational studies.

Authors:  M N Händel; J F Rohde; R Jacobsen; S M Nielsen; R Christensen; D D Alexander; P Frederiksen; B L Heitmann
Journal:  Eur J Clin Nutr       Date:  2020-02-06       Impact factor: 4.016

Review 2.  Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.

Authors:  Moshe Frenkel; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2017-10-14       Impact factor: 5.075

3.  Human T lymphocytes bioactivate heterocyclic aromatic amines by forming DNA adducts.

Authors:  Medjda Bellamri; Ludovic Le Hegarat; Laurent Vernhet; Georges Baffet; Robert J Turesky; Sophie Langouët
Journal:  Environ Mol Mutagen       Date:  2016-11-01       Impact factor: 3.216

4.  Association of rs2910164 in miR-146a with type 2 diabetes mellitus: A case-control and meta-analysis study.

Authors:  Wei-Wei Chang; Li-Ying Wen; Liu Zhang; Xin Tong; Yue-Long Jin; Gui-Mei Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-27       Impact factor: 6.055

5.  Association of Cancer Incidence and Duration of Residence in Geothermal Heating Area in Iceland: An Extended Follow-Up.

Authors:  Adalbjorg Kristbjornsdottir; Thor Aspelund; Vilhjalmur Rafnsson
Journal:  PLoS One       Date:  2016-05-20       Impact factor: 3.240

6.  Processed meat intake and chronic disease morbidity and mortality: An overview of systematic reviews and meta-analyses.

Authors:  Mina Nicole Händel; Isabel Cardoso; Katrine Marie Rasmussen; Jeanett Friis Rohde; Ramune Jacobsen; Sabrina Mai Nielsen; Robin Christensen; Berit Lilienthal Heitmann
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.